Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of the Efficacy and Safety of Tocilizumab in COVID-19
IRCT20151227025726N13Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Mar 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of tocilizumab in coronavirus pneumonia, sponsored by Shahid Beheshti University of Medical Sciences. Started Mar 2020; status: completed.
02
Drugs
tocilizumab
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20151227025726N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151227025726N13.